Physician profile
Billy May
NPI 1215927710
$4,859.40
in general payments reported to CMS, 2019-2025
42 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $812 · 2021: $1,107 · 2022: $849 · 2023: $792 · 2024: $516 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,665.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,561.38 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $379.74 | 2019-2023 | Cycloset |
| Takeda Pharmaceuticals U.S.A., INC. | $370.75 | 2019-2024 | Trintellix |
| Astrazeneca Pharmaceuticals Lp | $187.27 | 2019-2024 | Airsupra, Farxiga |
| Amarin Pharma, INC. | $185.40 | 2019-2021 | |
| Allergan, INC. | $175.96 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $162.44 | 2020-2025 | Unithroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.05 | 2020-2025 | Jardiance |
| Glaxosmithkline, LLC. | $151.51 | 2019-2024 | Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $130.74 | 2019-2025 | Zepbound, Mounjaro |
| Antares Pharma, INC. | $130.23 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Amgen INC. | $119.69 | 2019-2025 | Evenity, Prolia |
| Pfizer INC. | $111.14 | 2019-2021 | |
| Neos Therapeutics, Lp | $103.17 | 2019-2020 | |
| Abbott Laboratories | $78.98 | 2022-2023 | Freestyle Libre 3 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Billy May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.